02/28/2021
# Distribution and Sensibilization # #
The production of COVID-19 vaccines shines out the problem for biopharmaceutical companies and regulatory agencies. Given that one or more vaccines are licensed, several mechanisms to guide their ethical delivery remain debatable. However, even though intensive parallel efforts are on-going to increase supply, there is no assurance that sufficient supply will be available to everyone in just a short time. The need for temperature-controlled storage of some vaccines to prevent infections to patients with underlying conditions is also troublesome.
There seems to be no globalized structure in place for large-scale production and distribution. The World Health Organization (WHO) should ensure that the vaccines are not for highly developed nations but should legally be distributed to all affected countries. A global distribution system is necessary to execute such a magnanimous function. More so, it is time to take drastic measures to resolve logistics issues that have, for a long time, been affecting the healthcare industry. In my book;Med-chains & Covid 19 provides real solutions and a road map that can be used to mitigate similar issues... visit
Previous Next Dr. Ebot Eyong is the founder and CEO of E & E Medicals and Consulting. A full-service engineering, regulatory, and sales corporation for advanced medical devices, based in Atlanta, USA. Dr. Eyong is a Biomedical Engineer, Quality Assurance, and Regulatory Consultant. For more than a d...